A Study of Oral TP-3654 in Patients With Myelofibrosis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04176198 |
Recruitment Status :
Recruiting
First Posted : November 25, 2019
Last Update Posted : November 21, 2023
|
Sponsor:
Sumitomo Pharma America, Inc.
Information provided by (Responsible Party):
Sumitomo Pharma America, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | December 2024 |
Estimated Study Completion Date : | February 2025 |